Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients.
about
Circulating tumor cells: approaches to isolation and characterizationBone marrow micrometastases and circulating tumor cells: current aspects and future perspectives.A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patientsTranscriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival--Evidence from TCGA Pan-Cancer DataDetection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study.Detection of carcinoembryonic antigen messenger RNA in blood using quantitative real-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinomaTrefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinomaMolecular detection of peripheral blood breast cancer mRNA transcripts as a surrogate biomarker for circulating tumor cellsTrefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancerCirculating serum trefoil factor 3 (TFF3) is dramatically increased in chronic kidney disease.The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patientsRecent translational research: circulating tumor cells in breast cancer patientsExpression profiling of small cellular samples in cancer: less is more.Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction methodClinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.Detection of disseminated tumor cells in peripheral blood.Single cell analysis of cancer cells using an improved RT-MLPA method has potential for cancer diagnosis and monitoring.Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.Circulating tumor cells: detection, molecular profiling and future prospects.Novel clinical trial designs for innovative therapies.Enrichment, detection and clinical significance of circulating tumor cells.Combination of miR-21 with Circulating Tumor Cells Markers Improve Diagnostic Specificity of Metastatic Breast Cancer.Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.Detection of circulating tumor cells in peripheral blood of breast cancer patients during or after therapy using a multigene real-time RT-PCR assay.Detection of Disseminated Cancer Cells in Blood.
P2860
Q24631347-4F2D497A-3FA2-41D5-A796-E64C0EFF41B6Q24796185-E2CA6FC5-C46E-4786-A8A2-7414D0E1A693Q28731800-7EBB1B4C-87D5-451C-9944-8F83DD1A9B51Q31042305-2806856A-8F4A-4025-AEA0-7FDAC6CD55FAQ33320704-5006004D-7B37-4553-ADF2-6B5FD7C0CDD7Q34341338-320C2325-4443-4121-AF46-836D9F3A5E1DQ34411725-E0AC46BE-7461-40C8-B811-6274559435A8Q34994514-D978DD64-AB04-4D5E-B240-12E6D3C5E275Q35000231-3884495A-A3A6-4D93-8B44-89497B99E153Q35034712-0DEB75BB-6F35-4FAE-AB37-7AF2D3473243Q35055099-F7B66570-5C57-4076-AE52-7C56088F4FC7Q35558100-360E6517-DCCF-42B3-97E7-FC04EEB29A86Q35605832-FD25450C-5D8E-4E7B-9341-848DEF9D0D36Q35693851-57CD50B0-9BB8-48F9-BC0B-FEF4B3C2ADE8Q35790106-BA02C935-6904-40E9-9B3E-4ECB03F58CD9Q36072794-F3248133-852E-4F1C-B0A1-372B237F6F20Q36154564-1E29EB69-F769-4F2E-91EC-0470CCF2B6ECQ36272624-3331703D-829D-4E7B-AA8E-41ABBCB27D76Q36642525-33C74170-938B-4C06-BBB0-8AE8AA57EBCFQ37027492-2F0CD5F8-BC7B-4FFC-BC6E-EF3AE36DBA9AQ37358492-EAAED10C-38D9-4592-B295-81285E8B1CBEQ38102590-AB203483-001A-4A8B-A75B-582E084F5C1BQ39041226-C7E114FC-609B-41A4-8455-38C9C3E3C42EQ47109459-C7DF5DBC-5717-4797-A75F-DBD7400D316AQ51807980-128BBA0A-74F6-41F5-813E-CA92618A8CE4Q55333294-F07CEA18-3978-404A-A27B-0AFC63A34579
P2860
Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Marker genes for circulating t ...... asized breast cancer patients.
@ast
Marker genes for circulating t ...... asized breast cancer patients.
@en
type
label
Marker genes for circulating t ...... asized breast cancer patients.
@ast
Marker genes for circulating t ...... asized breast cancer patients.
@en
prefLabel
Marker genes for circulating t ...... asized breast cancer patients.
@ast
Marker genes for circulating t ...... asized breast cancer patients.
@en
P2093
P2860
P356
P1476
Marker genes for circulating t ...... asized breast cancer patients.
@en
P2093
A A M Hart
L J van 't Veer
S Rodenhuis
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600868
P407
P577
2003-04-01T00:00:00Z